RGRXD:RegeneRx Biopharmaceuticals Inc - Stock Price Quote and Dividend Data
RGRXD STOCK PRICE LATEST CLOSE
< $0.01
EXCHANGE
OTCBB
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
RegeneRx Biopharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
RegeneRx Biopharmaceuticals Inc Stock Price Information
52-Week Low/High Stock Price$0.00 - $0.07
Percent Held by Institutions0.00%
Revenue$95,951
Net Income$-2,073,790
Cash Flow$-1,013,080
EPS0.00%
Market Cap$2,010
PE Ratio0
PE Ratio to Industry125%
Debt-Equity Ratio1,000,000.00%
Debt-Equity to Industry2.02%
Total Return Last 12 Months0.00%
Total Return Last 3 Years-99.99%
Total Return Last 5 Years-99.99%
Latest Trade DateMar. 31, 2025
RegeneRx Biopharmaceuticals Inc Annual Stock Dividends
No Data available for Payment History.
RegeneRx Biopharmaceuticals Inc Dividend Payment History
| No dividends retrieved for RGRXD |
RegeneRx Biopharmaceuticals Inc Other Dividend Details
RegeneRX Biopharmaceuticals is a biopharmaceutical company focused on the development of a therapeutic peptide, Thymosin beta 4 (Tß4), for tissue and organ protection, repair, and regeneration. Co. has formulated Tß4 into three product candidates in clinical development: RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications that may be treated by systemic administration; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dec. 24, 2024RGRXD STOCK PRICE DECREASE: RegeneRx Biopharmaceuticals Inc on 12-24-2024 decreased stock price > 10% from $0.07 to $0.00
Dec. 19, 2024RGRXD STOCK PRICE INCREASE: RegeneRx Biopharmaceuticals Inc on 12-19-2024 increased stock price > 10% from $0.00 to $0.07
Dec. 19, 2024RGRXD STOCK PRICE 52 WEEK HIGH: RegeneRx Biopharmaceuticals Inc on 12-19-2024 hit a 52 week high of $0.07
Sep. 14, 2024RGRXD STOCK PRICE DECREASE: RegeneRx Biopharmaceuticals Inc on 09-14-2024 decreased stock price > 10% from $0.06 to $0.00
Sep. 05, 2024RGRXD STOCK PRICE INCREASE: RegeneRx Biopharmaceuticals Inc on 09-05-2024 increased stock price > 10% from $0.00 to $0.06
Jun. 14, 2024RGRXD STOCK PRICE DECREASE: RegeneRx Biopharmaceuticals Inc on 06-14-2024 decreased stock price > 10% from $0.05 to $0.00
Jun. 07, 2024RGRXD STOCK PRICE INCREASE: RegeneRx Biopharmaceuticals Inc on 06-07-2024 increased stock price > 10% from $0.00 to $0.05
May. 02, 2024RGRXD STOCK PRICE DECREASE: RegeneRx Biopharmaceuticals Inc on 05-02-2024 decreased stock price > 10% from $0.05 to $0.00
Apr. 11, 2024RGRXD STOCK PRICE INCREASE: RegeneRx Biopharmaceuticals Inc on 04-11-2024 increased stock price > 10% from $0.00 to $0.05
Oct. 20, 2023RGRXD STOCK PRICE DECREASE: RegeneRx Biopharmaceuticals Inc on 10-20-2023 decreased stock price > 10% from $0.97 to $0.00
Apr. 10, 2025IBO STOCK PRICE DECREASE: Impact Biomedical Inc on 04-10-2025 decreased stock price > 10% from $0.65 to $0.52
Apr. 10, 2025SXTP STOCK PRICE DECREASE: 60 Degrees Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $2.87 to $2.50
Apr. 10, 2025BMYMP STOCK PRICE DECREASE: $2 Cv. Pfd./Bristol Myers Squibb Co. on 04-10-2025 decreased stock price > 10% from $1,003.20 to $901.50
Apr. 10, 2025PBMWW STOCK PRICE DECREASE: Wt Exp/Psyence Biomedical Ltd on 04-10-2025 decreased stock price > 10% from $0.03 to $0.02
Apr. 10, 2025UPC STOCK PRICE DECREASE: Ord Shs (New)/Universe Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $3.95 to $3.28
Apr. 10, 2025SXTPW STOCK PRICE DECREASE: Wt Exp/60 Degrees Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $0.07 to $0.04
Apr. 10, 2025RGBP STOCK PRICE DECREASE: Regen BioPharma Inc on 04-10-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 10, 2025DRRX STOCK PRICE DECREASE: Durect Corp on 04-10-2025 decreased stock price > 10% from $0.80 to $0.71
Apr. 10, 2025IXHL STOCK PRICE DECREASE: Incannex Healthcare Inc on 04-10-2025 decreased stock price > 10% from $0.84 to $0.68
Apr. 10, 2025CLABF STOCK PRICE DECREASE: Com No Par/Core One Labs Inc on 04-10-2025 decreased stock price > 10% from $0.09 to $0.04
